Hyperglycaemia after Capromorelin (Entyce) in dogs

60 reports to the FDA describe hyperglycaemia in dogs given Capromorelin. That is 4.0% of all reports for this medicine, compared with 0.5% across reports for all dog medicines, so it is reported unusually often with this medicine.

60Reports

80%Marked serious

13%Recovered

47%Died or euthanised

3 daysTypical onset

How soon it started

Same day

16 32%

1–2 days

9 18%

3–7 days

10 20%

1–4 weeks

6 12%

Over a month

9 18%

How the animals did

Recovered

8 13%

Still unwell when reported

15 25%

Died

10 17%

Euthanised

18 30%

Not known

9 15%

Problems reported at the same time

33 55%

30 50%

28 47%

28 47%

25 42%

17 28%

16 27%

16 27%

Age of the animals

Under 1 year

1–3 years

4–7 years

8–11 years

12+ years

About this medicine

Capromorelin stimulates appetite.

Products with this ingredient include Entyce, Elura. The FDA hides brand names in its public data, so these reports cover every product with the same active ingredients.

Questions owners ask

Can Capromorelin cause hyperglycaemia in dogs?: 60 reports link the two, but a report alone does not prove the medicine was the cause: other illnesses, other medicines or coincidence can be involved. Your vet can judge it for your animal.
How soon after a dose was it reported?: In half of the reports with dates, it started within 3 days of the first dose.
What should I do?: Don't give another dose until you've spoken to your vet, and keep the packaging so you can tell them the product and dose. Your vet can also report it to the FDA (or you can, through the manufacturer or FDA form 1932a).

Hyperglycaemia with similar medicines

Hyperglycaemia after Maropitant (Cerenia) 288 reports · 2.4% of its reports

All reported side effects of Capromorelin in dogs · Medicines most reported with hyperglycaemia